Literature DB >> 16831988

Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection.

Rizwan A Manji1, Lin F Zhu, Nimrit K Nijjar, David C Rayner, Greg S Korbutt, Thomas A Churchill, Ray V Rajotte, Arvind Koshal, David B Ross.   

Abstract

BACKGROUND: Glutaraldehyde fixation (G-F) decreases but likely does not eliminate the antigenicity of bioprosthetic heart valves. Rejection (with secondary dystrophic calcification) may be why G-F xenograft valves fail, especially in young patients, who are more immunocompetent than the elderly. Therefore, we sought to determine whether rejection of G-F xenograft occurs and to correlate this with graft calcification. METHODS AND
RESULTS: Ascending aortas/valves (from rats [syngeneic] or guinea pigs [xenogeneic]) were transplanted (fresh or after 48 hour of G-F) into the infrarenal aortas of young rat recipients for 20 days. A xenogeneic group was also treated with steroids until graft harvest. The valves and media/adventitia were scored blindly for inflammation (0 to 4). Percent graft infiltration by T cells/macrophages was determined (immunohistochemistry), and rat IgG ELISAs were performed. There was >3 times more valve inflammation, >10 times more valve T-cell/macrophage infiltrate, and >3 times antibody rise in the G-F xenogeneic groups compared with the fresh syngeneic or the G-F syngeneic groups (P<0.05). There was >2 times more adventitial inflammation and T-cell/macrophage infiltrate in the xenogeneic groups (P<0.05). Steroid treatment decreased inflammation and antibody rise in the xenogeneic groups (P<0.05). Correlation analysis revealed media/adventitia inflammation (P=0.02) and percent macrophage (P=0.01) infiltration to be predictors of calcification.
CONCLUSIONS: G-F xenografts have cellular/humoral rejection and calcify secondarily.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831988     DOI: 10.1161/CIRCULATIONAHA.105.549311

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  61 in total

1.  Pericardial tissue for cardiovascular application: an in-vitro evaluation of established and advanced production processes.

Authors:  L Grefen; F König; M Grab; C Hagl; N Thierfelder
Journal:  J Mater Sci Mater Med       Date:  2018-11-03       Impact factor: 3.896

2.  Pulmonary valve replacement long after repair of tetralogy of Fallot.

Authors:  Yuichi Shiokawa; Hiromichi Sonoda; Yoshihisa Tanoue; Takahiro Nishida; Atsuhiro Nakashima; Ryuji Tominaga
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-05-08

3.  In situ observation and enhancement of leaflet tissue formation in bioprosthetic "biovalve".

Authors:  Marina Funayama; Yoshiaki Takewa; Tomonori Oie; Yuichi Matsui; Eisuke Tatsumi; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2014-11-05       Impact factor: 1.731

4.  Early structural degeneration of Mitroflow aortic valve: another issue in addition to the mismatch?

Authors:  Giovanni Ruvolo; Calogera Pisano; Carmela Rita Balistreri; Emiliano Maresi; Oreste Fabio Triolo; Vincenzo Argano; Carlo Bassano; Sara Rita Vacirca; Paolo Nardi; Augusto Orlandi
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

5.  Morphometrical and biomechanical analyses of a stentless bioprosthetic valve: an implication to avoid potential primary tissue failure.

Authors:  Hiroki Takaya; Shinya Masuda; Masaaki Naganuma; Ichiro Yoshioka; Goro Takahashi; Masatoshi Akiyama; Osamu Adachi; Kiichiro Kumagai; Shukei Sugita; Yoshikatsu Saiki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-06-28

Review 6.  In Search of the Ideal Valve: Optimizing Genetic Modifications to Prevent Bioprosthetic Degeneration.

Authors:  Benjamin Smood; Hidetaka Hara; David C Cleveland; David K C Cooper
Journal:  Ann Thorac Surg       Date:  2019-03-02       Impact factor: 4.330

7.  Pseudoaneurysm formation after medtronic freestyle porcine aortic bioprosthesis implantation: a word of caution.

Authors:  Brian R Englum; Elizabeth N Pavlisko; Molly C Mack; Asvin M Ganapathi; Matthew A Schechter; Jennifer M Hanna; G Chad Hughes
Journal:  Ann Thorac Surg       Date:  2014-10-07       Impact factor: 4.330

8.  Graft-specific immune tolerance is determined by residual antigenicity of xenogeneic extracellular matrix scaffolds.

Authors:  Ailsa J Dalgliesh; Mojtaba Parvizi; Manuela Lopera-Higuita; Jeny Shklover; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2018-08-18       Impact factor: 8.947

9.  Protein extraction and 2-DE of water- and lipid-soluble proteins from bovine pericardium, a low-cellularity tissue.

Authors:  Leigh G Griffiths; Leila Choe; Kelvin H Lee; Kenneth F Reardon; E Christopher Orton
Journal:  Electrophoresis       Date:  2008-11       Impact factor: 3.535

Review 10.  Abdominal obesity and the metabolic syndrome: a surgeon's perspective.

Authors:  Patrick Mathieu
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.